Works matching IS 17762596 AND DT 2015 AND VI 10 AND IP 2

Results: 13

Preventable and potentially preventable serious adverse reactions induced by oral protein kinase inhibitors through a database of adverse drug reaction reports.

Published in:

Targeted Oncology, 2015, v. 10, n. 2, p. 229, doi. 10.1007/s11523-014-0328-7

By:

Egron, Adeline;
Olivier-Abbal, Pascale;
Gouraud, Aurore;
Babai, Samy;
Combret, Sandrine;
Montastruc, Jean-Louis;
Bondon-Guitton, Emmanuelle

Publication type:

Article

The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer.

Published in:

Targeted Oncology, 2015, v. 10, n. 2, p. 235, doi. 10.1007/s11523-014-0329-6

By:

Smith, Donald;
Acquaviva, Jaime;
Sequeira, Manuel;
Jimenez, John-Paul;
Zhang, Chaohua;
Sang, Jim;
Bates, Richard;
Proia, David

Publication type:

Article

Targeting BRAF mutant metastatic colorectal cancer: clinical implications and emerging therapeutic strategies.

Published in:

Targeted Oncology, 2015, v. 10, n. 2, p. 179, doi. 10.1007/s11523-014-0330-0

By:

Tie, Jeanne;
Desai, Jayesh

Publication type:

Article

Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLC.

Published in:

Targeted Oncology, 2015, v. 10, n. 2, p. 247, doi. 10.1007/s11523-014-0332-y

By:

Bosc, Cecile;
Ferretti, Gilbert;
Cadranel, Jacques;
Audigier-Valette, Clarisse;
Besse, Benjamin;
Barlesi, Fabrice;
Decroisette, Chantal;
Lantuejoul, Sylvie;
Arbib, François;
Moro-Sibilot, Denis

Publication type:

Article

Regorafenib as a single-agent in the treatment of patients with gastrointestinal tumors: an overview for pharmacists.

Published in:

Targeted Oncology, 2015, v. 10, n. 2, p. 199, doi. 10.1007/s11523-014-0333-x

By:

Rey, Jean-Baptiste;
Launay-Vacher, Vincent;
Tournigand, Christophe

Publication type:

Article

Angiogenesis and tumor microenvironment: bevacizumab in the breast cancer model.

Published in:

Targeted Oncology, 2015, v. 10, n. 2, p. 189, doi. 10.1007/s11523-014-0334-9

By:

Trédan, Olivier;
Lacroix-Triki, Magali;
Guiu, Séverine;
Mouret-Reynier, Marie-Ange;
Barrière, Jérôme;
Bidard, François-Clément;
Braccini, Antoine-Laurent;
Mir, Olivier;
Villanueva, Christian;
Barthélémy, Philippe

Publication type:

Article

Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma.

Published in:

Targeted Oncology, 2015, v. 10, n. 2, p. 267, doi. 10.1007/s11523-014-0335-8

By:

Peters, Inga;
Dubrowinskaja, Natalia;
Tezval, Hossein;
Kramer, Mario;
Klot, Christoph;
Hennenlotter, Jörg;
Stenzl, Arnulf;
Scherer, Ralph;
Kuczyk, Markus;
Serth, Jürgen

Publication type:

Article

Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: randomized non-comparative phase IIIb NEXT trial.

Published in:

Targeted Oncology, 2015, v. 10, n. 2, p. 255, doi. 10.1007/s11523-014-0336-7

By:

Heigener, David;
Pereira, José;
Felip, Enriqueta;
Mazal, Juraj;
Manzyuk, Lyudmila;
Tan, Eng;
Merimsky, Ofer;
Sarholz, Barbara;
Esser, Regina;
Gatzemeier, Ulrich

Publication type:

Article

Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg).

Published in:

Targeted Oncology, 2015, v. 10, n. 2, p. 277, doi. 10.1007/s11523-014-0337-6

By:

Donini, M.;
Buti, S.;
Lazzarelli, S.;
Bozzetti, R.;
Rivoltini, L.;
Camisaschi, C.;
Castelli, C.;
Bearz, A.;
Simonelli, C.;
Lo Re, G.;
Mattioli, R.;
Caminiti, C.;
Passalacqua, R.

Publication type:

Article

Combination of individualized local control and target-specific agent to improve unresectable liver cancer managements: a matched case-control study.

Published in:

Targeted Oncology, 2015, v. 10, n. 2, p. 287, doi. 10.1007/s11523-014-0338-5

By:

Li, Jiaping;
Zhang, Fujun;
Yang, Jianyong;
Zhang, Yingqiang;
Wang, Yu;
Fan, Wenzhe;
Huang, Yonghui;
Wang, Wei;
Ran, Henry;
Ke, Shi

Publication type:

Article

Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature.

Published in:

Targeted Oncology, 2015, v. 10, n. 2, p. 297, doi. 10.1007/s11523-014-0350-9

By:

Ihnenfeld Arciénega, Isabel;
Imesch, Patrick;
Fink, Daniel;
Dedes, Konstantin

Publication type:

Article

Nintedanib: A Review of Its Use as Second-Line Treatment in Adults with Advanced Non-Small Cell Lung Cancer of Adenocarcinoma Histology.

Published in:

Targeted Oncology, 2015, v. 10, n. 2, p. 303, doi. 10.1007/s11523-015-0367-8

By:

Dhillon, Sohita

Publication type:

Article

Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.

Published in:

Targeted Oncology, 2015, v. 10, n. 2, p. 215, doi. 10.1007/s11523-014-0323-z

By:

Niess, Hanno;
Camaj, Peter;
Renner, Andrea;
Ischenko, Ivan;
Zhao, Yue;
Krebs, Stefan;
Mysliwietz, Josef;
Jäckel, Carsten;
Nelson, Peter;
Blum, Helmut;
Jauch, Karl-Walter;
Ellwart, Joachim;
Bruns, Christiane

Publication type:

Article